ELEVANCE HEALTH, INC. Income (Loss) from Equity Method Investments
ELEVANCE HEALTH, INC. (ELV) reported Income (Loss) from Equity Method Investments of $567.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-15.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-07-15
- ELEVANCE HEALTH, INC. income (loss) from equity method investments for the quarter ending 2026-06-30 was $262.00M, a 2083.33% increase year-over-year.
- ELEVANCE HEALTH, INC. income (loss) from equity method investments for the quarter ending 2026-03-31 was $305.00M, a 142.06% increase year-over-year.
- ELEVANCE HEALTH, INC. income (loss) from equity method investments for the quarter ending 2025-12-31 was $147.00M, a 818.75% increase year-over-year.
- ELEVANCE HEALTH, INC. income (loss) from equity method investments for the quarter ending 2025-09-30 was $113.00M, a 927.27% increase year-over-year.
- ELEVANCE HEALTH, INC. income (loss) from equity method investments for fiscal 2025 was $398.00M, a 39700.00% increase from fiscal 2024.
- ELEVANCE HEALTH, INC. income (loss) from equity method investments for fiscal 2024 was $1.00M.
- ELEVANCE HEALTH, INC. income (loss) from equity method investments for fiscal 2023 was -$33.00M, a 111.26% decline from fiscal 2022.
- ELEVANCE HEALTH, INC. income (loss) from equity method investments for fiscal 2022 was $293.00M, a 47.86% decline from fiscal 2021.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $262.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-15 | $567.00M 10-Q · filed 2026-07-15 | $714.00M derived: sum of 3 quarters · filed 2026-07-15 | $827.00M derived: sum of 4 quarters · filed 2026-07-15 |
| 2026-03-31 | $305.00M 10-Q · filed 2026-04-22 | $452.00M derived: sum of 2 quarters · filed 2026-04-22 | $565.00M derived: sum of 3 quarters · filed 2026-04-22 | $577.00M derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-12-31 | $147.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $260.00M derived: sum of 2 quarters · filed 2026-02-06 | $272.00M derived: sum of 3 quarters · filed 2026-07-15 | $398.00M 10-K · filed 2026-02-06 |
| 2025-09-30 | $113.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-21 | $125.00M derived: sum of 2 quarters · filed 2026-07-15 | $251.00M 10-Q · filed 2025-10-21 | $267.00M derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-06-30 | $12.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-15 | $138.00M 10-Q · filed 2026-07-15 | $154.00M derived: sum of 3 quarters · filed 2026-07-15 | $165.00M derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-03-31 | $126.00M 10-Q · filed 2026-04-22 | $142.00M derived: sum of 2 quarters · filed 2026-04-22 | $153.00M derived: sum of 3 quarters · filed 2026-04-22 | $154.00M derived: sum of 4 quarters · filed 2026-04-22 |
| 2024-12-31 | $16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $27.00M derived: sum of 2 quarters · filed 2026-02-06 | $28.00M derived: sum of 3 quarters · filed 2026-02-06 | $1.00M 10-K · filed 2026-02-06 |
| 2024-09-30 | $11.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-21 | $12.00M derived: sum of 2 quarters · filed 2025-10-21 | -$15.00M 10-Q · filed 2025-10-21 | $22.00M derived: sum of 4 quarters · filed 2026-02-06 |
| 2024-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-17 | -$26.00M 10-Q · filed 2025-07-17 | $11.00M derived: sum of 3 quarters · filed 2026-02-06 | $14.00M derived: sum of 4 quarters · filed 2026-02-06 |
| 2024-03-31 | -$27.00M 10-Q · filed 2025-04-22 | $10.00M derived: sum of 2 quarters · filed 2026-02-06 | $13.00M derived: sum of 3 quarters · filed 2026-02-06 | -$30.00M derived: sum of 4 quarters · filed 2026-02-06 |
| 2023-12-31 | $37.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $40.00M derived: sum of 2 quarters · filed 2026-02-06 | -$3.00M derived: sum of 3 quarters · filed 2026-02-06 | -$33.00M 10-K · filed 2026-02-06 |
| 2023-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-17 | -$40.00M derived: sum of 2 quarters · filed 2024-10-17 | -$70.00M 10-Q · filed 2024-10-17 | -$81.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | -$43.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-17 | -$73.00M 10-Q · filed 2024-07-17 | -$84.00M derived: sum of 3 quarters · filed 2025-02-20 | -$38.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | -$30.00M 10-Q · filed 2024-04-18 | -$41.00M derived: sum of 2 quarters · filed 2025-02-20 | $5.00M derived: sum of 3 quarters · filed 2025-02-20 | $110.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | -$11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $35.00M derived: sum of 2 quarters · filed 2025-02-20 | $140.00M derived: sum of 3 quarters · filed 2025-02-20 | $293.00M 10-K · filed 2025-02-20 |
| 2022-09-30 | $46.00M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2023-10-18 | $151.00M derived: sum of 2 quarters · filed 2023-10-18 | $304.00M 10-Q · filed 2023-10-18 | $429.00M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $105.00M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2023-09-29 | $258.00M 10-Q/A · filed 2023-09-29 | $383.00M derived: sum of 3 quarters · filed 2024-02-21 | $511.00M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $153.00M 10-Q · filed 2023-04-19 | $278.00M derived: sum of 2 quarters · filed 2024-02-21 | $406.00M derived: sum of 3 quarters · filed 2024-02-21 | $607.00M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $125.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $253.00M derived: sum of 2 quarters · filed 2024-02-21 | $454.00M derived: sum of 3 quarters · filed 2024-02-21 | $562.00M 10-K · filed 2024-02-21 |
| 2021-09-30 | $128.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-19 | $329.00M derived: sum of 2 quarters · filed 2022-10-19 | $437.00M 10-Q · filed 2022-10-19 | |
| 2021-06-30 | $201.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-20 | $309.00M 10-Q · filed 2022-07-20 | ||
| 2021-03-31 | $108.00M 10-Q · filed 2022-04-20 | |||
| 2020-12-31 | $51.00M 10-Q · filed 2023-10-18 | |||
| 2019-12-31 | $93.00M 10-K · filed 2022-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |